Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry

Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry

Bibliographic Details
Main Authors:	Chisato Terada, Kaho Oh, Ryutaro Tsubaki, Bun Chan, Nozomi Aibara, Kaname Ohyama, Masa-Aki Shibata, Takehiko Wada, Mariko Harada-Shiba, Asako Yamayoshi, Tsuyoshi Yamamoto
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-44590-4

Similar Items

Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
by: Chisato Terada, et al.
Published: (2023-12-01)

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021-05-01)

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
by: Fumito Wada, et al.
Published: (2021-12-01)

Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
by: Chisato Terada, et al.
Published: (2022-11-01)

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice
by: Tsuyoshi Yamamoto, et al.
Published: (2012-01-01)

Toeholds and Takeovers.
by: Bulow, J, et al.
Published: (1996)

Toeholds and Takeovers.
by: Bulow, J, et al.
Published: (1999)

Toeholds and Takeovers.
by: Bulow, J, et al.
Published: (2002)

Toeholder: a software for automated design and in silico validation of toehold riboswitches
by: Angel F. Cisneros, et al.
Published: (2023-06-01)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023-02-01)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Towards understanding and applications of antisense oligonucleotides
by: Nguyen, Le Tuan Anh
Published: (2020)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
by: Yu Mikame, et al.
Published: (2023-10-01)

Wrangling RNA: Antisense oligonucleotides for neurological disorders
by: Talbot, K, et al.
Published: (2019)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)

Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021-11-01)

Antisense oligonucleotide therapy for KCNT1 encephalopathy
by: Lisseth Estefania Burbano, et al.
Published: (2022-12-01)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish.
by: Andrea Pauli, et al.
Published: (2015-01-01)

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement
by: Alexander Batista-Duharte, et al.
Published: (2020-02-01)

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
by: Tomoko Nishina, et al.
Published: (2015-01-01)

Antisense Oligonucleotide Gene Therapy for Neuromuscular Disorders
by: Ryan Gotesman
Published: (2018-11-01)

Modelling toehold-mediated RNA strand displacement
by: Šulc, P, et al.
Published: (2015)

Cellular Computational Logic Using Toehold Switches
by: Seungdo Choi, et al.
Published: (2022-04-01)

Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes
by: Kiyoko Setoguchi, et al.
Published: (2017-12-01)

Antisense oligonucleotides: the next frontier for treatment of neurological disorders
by: Rinaldi, C, et al.
Published: (2017)

Selecting effective antisense reagents on combinatorial oligonucleotide arrays.
by: Milner, N, et al.
Published: (1997)

Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
by: Southern, E, et al.
Published: (1997)

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
by: Betts, C, et al.
Published: (2012)

OPTIMIZING THE DESIGN OF ANTISENSE THERAPEUTICS USING OLIGONUCLEOTIDE ARRAYS
by: Casegreen, S, et al.
Published: (1994)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Progress in the Treatment of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
by: XU Tingting, et al.
Published: (2022-04-01)

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
by: Clarice Gareri, et al.
Published: (2022-07-01)

The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
by: Sudhir Agrawal
Published: (2021-05-01)

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
by: Karishma Dhuri, et al.
Published: (2020-06-01)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
by: Valentina Giudice, et al.
Published: (2020-05-01)

Antisense oligonucleotides: a novel Frontier in pharmacological strategy
by: D. Collotta, et al.
Published: (2023-11-01)